Clinical Trials
50 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
SUNRAY-01
Eli Lilly and Company
LADOGA
AstraZeneca
RehabKBP
University Hospital, Toulouse
NADIM-ADJUVANT
Fundación GECP
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Weill Medical College of Cornell University
LIBRETTO-001
Eli Lilly and Company
ETCABIO
University Hospital, Angers
REVIVE
AstraZeneca
AcceleRET-Lung
Hoffmann-La Roche
LOTOS
AstraZeneca
VALOR
VA Office of Research and Development
EBNK-ST-001
Essen Biotech
LIBRETTO-121
Eli Lilly and Company
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Qilu Pharmaceutical Co., Ltd.
BCBPoumon
Institut du Cancer de Montpellier - Val d'Aurelle
ARROW
Hoffmann-La Roche
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
APOLO
Fundación GECP
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Fundación GECP
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
Blueprint Medicines Corporation
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Blueprint Medicines Corporation
A Phase â…¡ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Nanfang Hospital, Southern Medical University
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
Weill Medical College of Cornell University
CANUT-2
Hospices Civils de Lyon
ALpha-T
Hoffmann-La Roche
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
Blueprint Medicines Corporation
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
ENCORE110
Syndax Pharmaceuticals
Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
Fondation Hôpital Saint-Joseph
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
H. Lee Moffitt Cancer Center and Research Institute
EPIC
University of Turin, Italy
OnkoFit II
University Hospital Tuebingen
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
VTNSCLC
VA Office of Research and Development
BOOST
University College London Hospitals
A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection
Shanghai Gebaide Biotechnology Co., Ltd.
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Wuxi No. 4 People's Hospital
SAS CA
RWTH Aachen University
NEOSAS
University Hospital, Angers
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Valerio Therapeutics
Phase II Study of Lucanixâ„¢ in Patients With Stages II-IV Non-Small Cell Lung Cancer
NovaRx Corporation
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
Pharmacyclics LLC.
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training
German Cancer Research Center
Diagnostic Effectiveness of Virtual Bronchoscopy
National Institutes of Health Clinical Center (CC)
Randomized Trial of Fluticasone in Bronchial Premalignancy
Amsterdam UMC, location VUmc